01-17-2019 01:33 PM CET - Business, Economy, Finances, Banking & Insurance
Print

Tendinitis Treatment Market 2018 Expected To Surpass USD 426.4 Million By The End Of 2023 | Top Key Players - AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc and others

Press release from: Market Research Future
Tendinitis treatment market
Tendinitis treatment market


Market Scenario:

Tendinitis is the inflammation of the tendon, thick cords that attach the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction. Tendinitis is found to be prevalent among athletes and is one of the common sport injuries in sport players, especially tennis, golf and others. Various pharmacological and non-pharmacological treatments are available for the treatment of tendinitis. Non-steroidal anti-inflammatory drugs (NSAIDs) constitute the preliminary treatment options. Other treatments including physical therapy, rest, and occupational therapy. Surgery is the last resort for tendinitis, and is only recommended in case of severe damage to the tendon that cannot be treated using pharmacological treatment options.

Get Sample Copy @ www.marketresearchfuture.com/sample_request/3876

Global tendinitis treatment market is expected to grow at the CAGR of ~3.8% during the forecast period and is estimated to reach USD 426.4 million by 2023. According to a recent study report published by the Market Research Future, the global tendinitis treatment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017 – 2023).

Key players for Global Tendinitis Treatment Market:

Almatica Pharma, Inc. (US),
AstraZeneca (US),
Bayer (Germany),
Boehringer Ingelheim Pharmaceuticals, Inc. (US),
Merck & Co., Inc (US),
Pfizer (US).
Segments:

Global tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's knee, and others.

On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.

On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Intended Audience:

Tendinitis medicines manufacturers

Tendinitis medicines and treatment providers

Medical Research laboratories

Research and Development (R&D) Companies

Market Research and Consulting Service Providers

Potential Investors

Regional analysis of global Tendinitis treatment market:

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly includes North America and South America. Due to developed healthcare infrastructure and increasing R&D funding, US is dominating country in this region. Europe is second largest market for tendinitis treatment. Due to innovative product development and rapid adoption of new treatments, Germany is dominating this market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and Africa is expected to have limited growth while Middle Eastern countries are expected to dominate this market during the forecast period.

Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ www.marketresearchfuture.com/reports/tendinitis-treatment...

Detailed Table of Contents:

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

11 Competitive Landscape

12 Company Profile

13 Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Tendinitis Treatment Market

14 Appendix

...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.
News-ID: 1508441 • Views: 74
More releasesMore releases

You can edit or delete your press release here: